These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1745841)

  • 21. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled fluticasone in bronchiectasis: a 12 month study.
    Tsang KW; Tan KC; Ho PL; Ooi GC; Ho JC; Mak J; Tipoe GL; Ko C; Yan C; Lam WK; Chan-Yeung M
    Thorax; 2005 Mar; 60(3):239-43. PubMed ID: 15741443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.
    Stockley R; De Soyza A; Gunawardena K; Perrett J; Forsman-Semb K; Entwistle N; Snell N
    Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis.
    De Soyza A; Pavord I; Elborn JS; Smith D; Wray H; Puu M; Larsson B; Stockley R
    Eur Respir J; 2015 Oct; 46(4):1021-32. PubMed ID: 26341987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
    Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B;
    Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bromhexine and guaiphenesine on clinical state, ventilatory capacity and sputum viscosity in chronic asthma.
    Heilborn H; Pegelow K-O ; Odeblad E
    Scand J Respir Dis; 1976; 57(2):88-96. PubMed ID: 781835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
    Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
    J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of a chronic purulent bronchitis with a new drug combination].
    Schachtner J
    Med Welt; 1976 Feb; 27(6):262-5. PubMed ID: 1256287
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromhexine in severe asthma.
    Rudolf M; Riordan JF; Grant BJ; Maberly DJ; Saunders KB
    Br J Dis Chest; 1978 Oct; 72(4):307-12. PubMed ID: 365213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J; Jirou-Najou JL
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.
    Quittner AL; O'Donnell AE; Salathe MA; Lewis SA; Li X; Montgomery AB; O'Riordan TG; Barker AF
    Thorax; 2015 Jan; 70(1):12-20. PubMed ID: 25323621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis.
    Lin HC; Cheng HF; Wang CH; Liu CY; Yu CT; Kuo HP
    Am J Respir Crit Care Med; 1997 Jun; 155(6):2024-9. PubMed ID: 9196111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.
    Briffa PJ; Anderson SD; Burton DL; Young IH
    Respirology; 2011 Jan; 16(1):161-6. PubMed ID: 21054671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.